Pathological Conditions, Signs and Symptoms: News and Research on Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

MeSH tree: C23.550.291.500.813

FDA approves self-injection of Vyvgart Hytrulo

The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with generalized myasthenia gravis (gMG) who are ...

Apr 16, 2025

0

28

CIDP study explores dual-target CAR-T cell therapy for the treatment of relapsed/refractory autoimmune disorders

Chinese scientists reveal the feasibility, tolerability, and efficacy of BCMA-CD19 bispecific CAR T-cells for treating chronic inflammatory demyelinating polyneuropathy (CIDP) and highlight the potential of CAR-T cell therapy ...

Jun 20, 2024

0

51